Previously, it was reported that genetically-influenced lower TG levels through LPL have an additive lowering effect on CAD risk on top of genetically-influenced lower LDL-C (21, 29), which were confirmed by the beneficial effects of this combination on the lipoprotein profile recently shown by our group (30). This evidence concerns the gene LPL and coronary artery disorder.